Vitality Watch

Dossier pubmed review 10-nov-2026
Narrative review or expert overview without new data

GLP-1-Based Therapies Across the Menopausal Transition: Dermatologic Considerations and Practical Management.

Key claim: GLP-1-induced rapid weight loss in perimenopausal and menopausal women exacerbates estrogen-related declines in skin elasticity, lean muscle, and bone density, warranting a proactive tissue-preservation approach.

Abstract

BACKGROUND: Glucagon-like peptide-1-based therapies have transformed obesity management. Their growing use among perimenopausal and menopausal women introduces new dermatologic considerations, particularly when weight loss occurs alongside menopause-associated changes in skin, adipose tissue, muscle, bone, and hair. OBJECTIVE: To provide a practical framework for dermatologic management of perimenopausal and menopausal women receiving glucagon-like peptide-1-based therapies. METHODS: PubMed was searched from inception through September 2026 for literature on Glucagon-like peptide-1-based therapies, menopause, skin aging, lean mass, alopecia, and aesthetic procedures. Reference lists of relevant reviews and consensus statements were also hand-searched. The senior author, a dermatologist and obesity medicine specialist, provides a practice-based perspective. RESULTS: Key considerations include weight-loss trajectory, lean mass and bone preservation, nutrition, hair changes, procedural timing, and multidisciplinary comanagement. A staged aesthetic approach prioritizes skin quality during active weight loss, with structural correction as weight stabilizes. CONCLUSION: Dermatologic care should anticipate the overlapping effects of menopause and substantial weight loss. A longitudinal, tissue-preservation approach may shift care from reactive correction toward proactive management.

Why this matters

GLP-1-induced rapid weight loss in perimenopausal and menopausal women exacerbates estrogen-related declines in skin elasticity, lean muscle, and bone density, warranting a proactive tissue-preservation approach.

Source

Link

Briefing card

GLP-1-Based Therapies Across the Menopausal Transition: Dermatologic Considerations and Practical Management.
Stage: review · pubmed · 10-nov-2026

GLP-1-induced rapid weight loss in perimenopausal and menopausal women exacerbates estrogen-related declines in skin elasticity, lean muscle, and bone density, warranting a proactive tissue-preservation approach.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1097/DSS.0000000000005459

build build 880 · 2bcef25 · 2026-11-18